SCHEMBL29566650

SCHEMBL29566650

Cc1cccc(C)c1-c1cc(Oc2cc(C(=O)O)ccc2Cl)nc(NS(=O)(=O)c2cccc(N)c2)n1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FABP4 P15090 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TSHR P16473 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ PTK2B Q14289 1/20 0.39
▸ KMT2A Q03164 4/20 0.38
▸ MEN1 O00255 3/20 0.37
▸ POLB P06746 1/20 0.36
▸ WDR5 P61964 2/20 0.36
▸ CCR2 P41597 1/20 0.36
▸ ACLY P53396 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ SENP8 Q96LD8 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36
▸ SENP6 Q9GZR1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310281 1.00 FABP4 (0.40) FABP4KDM4EALDH1A1LMNATSHR
SCHEMBL24309280 0.93 TSHR (0.46) FABP4KDM4EALDH1A1LMNATSHR
SCHEMBL29567236 0.93 TSHR (0.46) FABP4KDM4EALDH1A1LMNATSHR
SCHEMBL29515241 0.92 TSHR (0.41) ALDH1A1TSHRSMN1; SMN2KMT2AMEN1
SCHEMBL29567195 0.92 PCTP (0.39) ALDH1A1LMNATSHRSMN1; SMN2KMT2A
SCHEMBL24310526 0.92 PCTP (0.39) ALDH1A1LMNATSHRSMN1; SMN2KMT2A
SCHEMBL24310290 0.87 ALDH1A1 (0.44) ALDH1A1LMNAPOLB
SCHEMBL24310316 0.87 TSHR (0.45) KDM4EALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL29566632 0.87 TSHR (0.45) KDM4EALDH1A1LMNATSHRSMN1; SMN2
SCHEMBL29567166 0.86 TSHR (0.43) ALDH1A1LMNATSHRSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback